
Neuromuscular Specialist

No OPD information available
Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease)
Inclusion Body Myositis
Myositis
Primary Lateral Sclerosis
CHARGE Syndrome
Amyotonia Congenita
Anti-NMDA Receptor Encephalitis
Becker Muscular Dystrophy
Congenital Fiber-Type Disproportion
Cramp-Fasciculation Syndrome
Dehydration
Merrilee A. Needham is a female healthcare provider who helps people with different conditions like ALS, myositis, and more. She uses her special skills to treat patients with care and expertise. Merrilee communicates well with her patients, making them feel comfortable and safe. Patients trust her because she listens to them and explains things clearly.
Merrilee stays updated with the latest medical knowledge and research to provide the best care for her patients. She works closely with other medical professionals, sharing her knowledge and learning from them too. Her relationships with colleagues are strong, and they collaborate to give the best possible care to patients.
Merrilee's work has positively impacted many patients' lives. She has helped improve their health and well-being through her treatments and care. Her dedication to her patients shines through in everything she does.
One of Merrilee's notable publications is about pain, fatigue, and physical function in adults with myopathies. She also conducted a clinical trial for patients with Inclusion Body Myositis. These research efforts show her commitment to advancing medical knowledge and finding better treatments for her patients.
In summary, Merrilee A. Needham is a compassionate and skilled healthcare provider who goes above and beyond to help her patients. Her dedication to staying informed, collaborating with colleagues, and conducting research shows her commitment to providing the best care possible. Patients trust Merrilee because of her excellent communication skills and the positive impact she has on their lives.
Enrollment Status: Completed
Published: February 20, 2025
Intervention Type: Drug
Study Drug: ABC008
Study Phase: Phase 1
